Sample Case #1
Q: A sponsor is developing a NME which will have use in both the adult & pediatric population. They have presented their pediatric drug development plan at the end of Phase II meeting. At the pre-NDA meeting the sponsor stated they will be on target & will have two of the three discussed pediatric studies ready to be submitted with the NDA application.